Movement Alert｜Hinge Health, Inc. Rises 5.15% in Regular Trading, BofA Sees Strong Growth Outlook

Market Focus10-10

On October 10, Hinge Health, Inc. rose 5.15% in regular trading, trading at $103.05 per share, with turnover of $144 million.

BofA Securities stated that Hinge Health's growth outlook is supported by higher member participation, expansion of its eligible population, and adoption of newer products. The firm forecasts billings growth of 45% in 2026, 29% in 2027, and 25% in 2028, each above consensus. BofA also believes management's target of adding 4 million to 5 million eligible lives annually could push 2027 and 2028 billings at least 5% to 7% above Wall Street forecasts.

According to the latest quarterly report, Hinge Health delivered Q2 adjusted earnings of $0.59 per share and revenue of $212.8 million, with full-year revenue guidance raised to $856 million to $860 million.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment